GlassScriptPhysician profile
Candace R Harris
NPI 1942787833
$1,764.87
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $539 · 2022: $329 · 2023: $788 · 2024: $109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $830 · Education: $66.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $829.50 |
| Education | $66.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $361.07 | 2021-2023 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $230.97 | 2021-2024 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $170.46 | 2021-2023 | Farxiga |
| Novartis Pharmaceuticals Corporation | $131.44 | 2021-2023 | |
| Baxter Healthcare | $114.84 | 2023-2024 | Hillrom - Carnation Ambulatory Monitor |
| Actelion Pharmaceuticals US, INC. | $92.08 | 2023 | Opsumit, Uptravi |
| Amgen INC. | $82.16 | 2021-2023 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $64.94 | 2022-2023 | Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $59.77 | 2021-2023 | Jardiance |
| Esperion Therapeutics, INC. | $52.71 | 2021-2022 | |
| Irhythm Technologies, INC. | $52.26 | 2022-2023 | Zio Xt Patch |
| Pfizer INC. | $51.14 | 2022-2023 | |
| Lexicon Pharmaceuticals, INC. | $40.69 | 2023 | Inpefa |
| Medtronic, INC. | $40.03 | 2021-2023 | Micra |
| Novo Nordisk INC | $38.11 | 2023 | Wegovy, Ozempic |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals, LTD. | $36.19 | 2023 | Arcalyst |
| Sanofi-Aventis U.S. LLC | $35.49 | 2023 | |
| Abiomed | $31.50 | 2021-2023 | Impella |
| Bardy Diagnostics, INC. | $30.00 | 2021 | |
| Merck Sharp & Dohme LLC | $23.73 | 2021-2022 | |
| Astellas Pharma US INC | $13.46 | 2021 | |
| Abbvie INC. | $11.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Candace Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.